Drug Database
J05AP51 sofosbuvir and ledipasvir
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Harvoni 33.75 mg/150 mg and 45 mg/200 mg coated granules ▼
- POM Harvoni 33.75 mg/150 mg coated granules in sachet ▼
- POM Harvoni 33.75 mg/150 mg coated granules in sachet (Northern Ireland) ▼
- POM Harvoni 45 mg/200 mg coated granules in sachet ▼
- POM Harvoni 45 mg/200 mg coated granules in sachet (Northern Ireland) ▼
- POM Harvoni 45 mg/200 mg film-coated tablets
- POM Harvoni 45 mg/200 mg film-coated tablets SmPC (Northern Ireland) ▼
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).